ZoBio Awarded the Company Showing Best Growth Results!

At the recent annual network event organized by Libertatis Ergo Holding BV (LEH) at Leiden Bio Science Park (LBSP) ZoBio was awarded #1 company in the category: Company showing best growth results!
On the premises of LBSP more than 150 biomedical life science companies…

Contributing All the Way to the Clinic

Recently the ZoBio team made an important contribution to a drug discovery project for our client Mirati Therapeutics that we are particularly proud of and has had significant impact [1]. This work describes a program to develop inhibitors of the epigenetic target PRMT5 with the potential to …

Eurostars DiscoveRNA Project Awarded!

RNA as a potential drug target is currently gaining a lot of interest, but the right technologies are not all in place to successfully pursue them. ZoBio and its partner ETH Zurich have been awarded with a €1.2 million EUREKA Eurostars grant, to establish an automated pipeline enabling…